STOCK TITAN

Aditxt (ADTX) details stockholder voting from reconvened special meeting

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Aditxt, Inc. held a reconvened special meeting of stockholders on February 13, 2026, after adjourning the original January 30, 2026 virtual meeting to allow more time for voting. A total of 516,567 shares of common stock, representing 33.39% of the voting authority, were present virtually, in person, or by proxy, which constituted a quorum.

Stockholders voted on several matters, with detailed results reported for each item, including votes for, against, abstain, and broker non-votes. One proposal received 455,456 votes for and 40,462 against, and another received 424,426 votes for and 75,505 against, indicating substantial participation across the agenda items.

Positive

  • None.

Negative

  • None.
false 0001726711 0001726711 2026-02-13 2026-02-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 13, 2026

 

Aditxt, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-39336   82-3204328
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

2569 Wyandotte Street, Suite 101, Mountain View, CA   94043
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (650) 870-1200

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425 )
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001   ADTX   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On February 13, 2026, Aditxt, Inc. (the “Company”) reconvened its special meeting of stockholders (the “Reconvened Special Meeting”), which was initially held on January 30, 2026 in virtual format and adjourned until February 13, 2026 in order to allow for additional time for the Company’s stockholders to vote. An aggregate of 516,567 shares of the Company’s common stock or 33.39% of the voting authority, constituting a quorum, were represented virtually, in person, or by valid proxies at the Reconvened Special Meeting.

 

Set forth below is a brief description of the matters voted upon at the Reconvened Special Meeting and the voting results with respect to such matters.

 

1.The vote to approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series A-1 Convertible Preferred Stock originally issued by the Company in December 2023 (the “Series A-1 Proposal”), was as follows:

 

FOR   AGAINST   ABSTAIN   BROKER NON-VOTE
             
146,657   38,053   7,108   324,749

 

2.The vote to approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series C-1 Convertible Preferred Stock and common stock purchase warrants originally issued by the Company in May 2024 and August 2024 (the “Series C-1 Proposal”), was as follows:

 

FOR   AGAINST   ABSTAIN   BROKER NON-VOTE
             
147,091   37,517   7,210   324,749

 

3.The vote to approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying common stock purchase warrants originally issued by the Company in July 2024 (the “July Warrant Proposal”), was as follows:

 

FOR   AGAINST   ABSTAIN   BROKER NON-VOTE
             
153,345   31,287   7,186   324,749

 

4.The vote to approve the Company’s 2025 Employee Stock Purchase Plan (the “ESPP”) (the “ESPP Proposal”), was as follows:

 

FOR   AGAINST   ABSTAIN   BROKER NON-VOTE
             
158,645   25,674   7,499   324,749

 

5.The vote to approve an amendment to our 2021 Omnibus Equity Incentive Plan (the “2021 Plan”) to increase the number of shares of common stock issuable thereunder to 350,000 shares from 3 shares (the “Equity Incentive Proposal”), was as follows:

 

FOR   AGAINST   ABSTAIN   BROKER NON-VOTE
             
147,125   37,551   7,142   324,749

 

-1-

 

 

6.At the Meeting, the vote to consider and cast a non-binding, advisory vote on the Company’s proposed amendment to its Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to change the Company’s name from “Aditxt, Inc.” to “bitXbio, Inc.” (the “Name Change Proposal”), was as follows:

 

FOR   AGAINST   ABSTAIN   BROKER NON-VOTE
             
455,456   40,462   20,649   0

 

7.At the Meeting, the vote to grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-five (1:5) to a maximum of a one-for-two hundred fifty (1:250) split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the “Reverse Split Proposal”), was as follows:

 

FOR   AGAINST   ABSTAIN   BROKER NON-VOTE
             
424,426   75,505   16,636   0

 

8.At the Meeting, the vote to authorize the adjournment of the Special Meeting if necessary or appropriate, including to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting or adjournment or postponement thereof to approve any of the foregoing proposals (the “Adjournment Proposal”), was as follows:

 

FOR   AGAINST   ABSTAIN   BROKER NON-VOTE
             
439,714   59,789   17,064   0

 

-2-

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: February 13, 2026

 

  Aditxt, Inc.
     
  By: /s/ Amro Albanna
  Name:  Amro Albanna
  Title: Chief Executive Officer

 

-3-

 

FAQ

What did Aditxt, Inc. (ADTX) report in its February 13, 2026 special meeting 8-K?

Aditxt reported results of a reconvened special stockholder meeting held February 13, 2026. The filing details quorum levels and vote counts, including for, against, abstain, and broker non-votes, across multiple proposals presented to common stockholders.

How many Aditxt (ADTX) shares were represented at the reconvened special meeting?

A total of 516,567 shares of Aditxt common stock were represented. This amount equaled 33.39% of the voting authority, which the company reported was sufficient to constitute a quorum for conducting business at the reconvened special meeting.

Why did Aditxt (ADTX) reconvene its special meeting of stockholders?

Aditxt reconvened its special meeting on February 13, 2026 after first holding it January 30, 2026. The original meeting was adjourned to allow additional time for stockholders to vote on the proposals presented at the special meeting.

What were some of the key vote totals at Aditxt’s (ADTX) reconvened special meeting?

One proposal received 455,456 votes for, 40,462 against, and 20,649 abstain. Another proposal recorded 424,426 for, 75,505 against, and 16,636 abstain, illustrating meaningful participation across the agenda.

Did broker non-votes affect Aditxt (ADTX) special meeting results?

For some proposals, Aditxt reported substantial broker non-votes, including 324,749 broker non-votes in several vote lines. For other proposals, broker non-votes were listed as zero, indicating those items were fully voted without broker non-voting positions.

What percentage of voting power did Aditxt (ADTX) say was present at the special meeting?

Aditxt stated that 33.39% of the voting authority was represented by the 516,567 common shares present. This level of representation was described as constituting a quorum, allowing the company to conduct the reconvened special meeting’s business.

Filing Exhibits & Attachments

3 documents
Aditxt Inc

NASDAQ:ADTX

ADTX Rankings

ADTX Latest News

ADTX Latest SEC Filings

ADTX Stock Data

1.23M
1.78M
0.79%
2.64%
Biotechnology
Pharmaceutical Preparations
Link
United States
RICHMOND